Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study.

导出 LinkOut

翻译打印收藏纠错

作者： Derrick,Lopez ^[1] ; Douglas,Pritchard ^[2] ; Frank M,Sanfilippo ^[3] ; Erin,Kelty ^[3] ; Amy,Page ^[4] ; Christopher,Etherton-Beer ^[2] ; Osvaldo P,Almeida ^[5] ; David B,Preen ^[3]

作者单位： School of Population and Global Health, The University of Western Australia, Crawley, Western Australia 6009, Australia. Electronic address: derrick.lopez@uwa.edu.au. ^[1] Medical School, The University of Western Australia, Crawley, Western Australia 6009, Australia. ^[2] School of Population and Global Health, The University of Western Australia, Crawley, Western Australia 6009, Australia. ^[3] School of Allied Health, The University of Western Australia, Crawley, Western Australia 6009, Australia. ^[4] Medical School, The University of Western Australia, Crawley, Western Australia 6009, Australia; Institute for Health Research, University of Notre Dame Australia, Australia. ^[5]

关键词 Antiviral Agents/therapeutic use Australia Covid-19 Humans Public health

主题词人类(Humans);回顾性研究(Retrospective Studies);男(雄)性(Male);女(雌)性(Female);老年人(Aged);抗病毒药(Antiviral Agents);利托纳韦(Ritonavir);中年人(Middle Aged);澳大利亚(Australia);胞苷(Cytidine);老年人, 80以上(Aged, 80 and over);羟胺类(Hydroxylamines);脯氨酸(Proline);吲唑类(Indazoles);复方合剂(Drug Combinations)

DOI 10.1016/j.idnow.2024.104953

PMID 38964717

发布时间 2024-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Infectious diseases now

2024年54卷6期

104953页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study.

Infectious diseases now

相似文献

Infectious diseases now

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study.

Infectious diseases now

相似文献

Infectious diseases now

相关期刊

检索历史清除